Pinkwashing & Breast Cancer

Billions of dollars have been raised through the tireless efforts of women and men devoted to putting an end to breast cancer. Yet, breast cancer rates in North America have risen to 1 in 8. “What’s going on?” asks Barbara Brenner in Pink Ribbons, Inc. a new film now playing across Canada.

This feature documentary visits some of the massive fundraising runs and questions where the money goes and asks ‘who really profits from pink ribbon campaigns?’. We meet women with metastatic breast cancer from the IV League support group of Austin, Texas who openly tell us their stories.

GreenMedInfo.com has been a tireless advocate to educating women to the unintended, adverse health effects of conventional breast cancer diagnostic technologies, as well as treatments.  View our section on the topic here: Health Guide: Breast Cancer

Other relevant sections include:

Diseases

• Breast Cancer : CK(2335) : AC(621)
• Breast Cancer: Bone Metastasis : CK(19) : AC(8)
• Breast Cancer: Chemically-Induced : CK(5) : AC(3)
• Breast Cancer: Conventional Treatment : CK(14) : AC(1)
• Breast Cancer: Diagnosis : CK(30) : AC(3)
• Breast Cancer: Ductal Carcinoma In Situ : CK(111) : AC(11)
• Breast Cancer: Estrogen : CK(5) : AC(2)
• Breast Cancer: estrogen receptor alpha-positive : CK(3) : AC(2)
• Breast Cancer: Lumpectomy/Post-Lumpectomy : CK(11) : AC(2)
• Breast Cancer: Triple Negative : CK(61) : AC(13)
• Breast Cancer Stem Cells : CK(11) : AC(1)
• Cancers: Estrogen Responsive : CK(3) : AC(3)
• Cancers: Multi-Drug Resistant : CK(92) : AC(73)
• Cancers: Radiation-Induced : CK(3) : AC(1)
• Chemotherapy : CK(65) : AC(16)
• Chemotherapy Induced Myelotoxicity : CK(48) : AC(13)
• Chemotherapy-Induced Toxicity: Tamoxifen : CK(6) : AC(3)
• Estrogen Dominance : CK(106) : AC(37)
• Estrogen Dysregulation: 2/4/16 hydroxyestrone ratios : CK(40) : AC(9)
• Fibrocystic Breast Disease : CK(62) : AC(7)

Therapeutic Actions

• Thermography : CK(20) : AC(2)

Anti Therapeutic Actions

• Breast Biopsy : CK(25) : AC(7)
• Chemotherapy : CK(257) : AC(38)
• High Bone Density : CK(131) : AC(14)
• Lumpectomy : CK(10) : AC(1)
• Radation Exposure: Low-Dose : CK(55) : AC(9)
• X-ray Diagnostic Technologies : CK(382) : AC(52)
• X-ray Mammography : CK(339) : AC(49)
• X-ray Mammography: Digital : CK(10) : AC(1)

Pharmacological Actions

• Aromatase Inhibitors : CK(33) : AC(23)
• BRCA-1 Downregulation : CK(2) : AC(2)
• Breast cancer resistance protein (BCRP) down-regulation : CK(1) : AC(1)

Adverse Pharmacological Actions

• Aromatase Disruptor : CK(1) : AC(1)

Problem Substances

• Arimidex : CK(122) : AC(12)
• Aromatase Inhibitor Drugs : CK(360) : AC(21)
• Exemestane : CK(30) : AC(3)
• Letrozole (trade name Femera) : CK(84) : AC(10)
• Oral Contraceptives : CK(287) : AC(24)

Additional Keywords

• 30 KVp X-Rays : CK(1) : AC(1)
• Breast Cancer and Exercise : CK(10) : AC(1)
• DCIS : CK(21) : AC(3)
• Drug: Letrozole : CK(2) : AC(1)
• Drug: Tamoxifen : CK(380) : AC(57)
• Superiority of Ultrasound to X-ray Mammography : CK(10) : AC(1)